Entvantage Diagnostics Financing
Entvantage Diagnostics, Inc., Corporation just submitted form D about $2.50 million equity financing. The date of first sale was 2016-07-12. Entvantage Diagnostics was able to sell $1.45 million so far. That is 58.00% of the financing round. The total private offering amount was $2.50 million. The form was filed on 2016-11-22. The reason for the financing was: unspecified. The fundraising still has about $1.05 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Entvantage Diagnostics is based in Texas. The company’s business is Other Health Care. The form was submitted by Joseph Skraba President and Chief Executive Officer. The company was incorporated in 2014. The filler’s address is: 4200 Marathon Blvd., Suite 200, Austin, Tx, Texas, 78756. Richard Hawkins is the related person in the form and it has address: 4200 Marathon Blvd, Suite 200, Austin, Tx, Texas, 78756. Link to Entvantage Diagnostics Filing: 000161915916000006.
Analysis of Entvantage Diagnostics Offering
On average, companies in the Other Health Care sector, sell 68.60% of the total offering size. Entvantage Diagnostics sold 58.00% of the offering. The financing is still open. The average investment offering size for companies in the Other Health Care industry is $1.16 million. The total amount raised is 25.00% bigger than the average for companies in the Other Health Care sector. The minimum investment for this fundraising was set at $25000. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Entvantage Diagnostics Also
The Form D signed by Joseph Skraba might help Entvantage Diagnostics, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.